Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis.
Br J Dermatol
; 187(3): 438-441, 2022 09.
Article
en En
| MEDLINE
| ID: mdl-35257363
ABSTRACT
Secukinumab showed consistent and sustained efficacy in clearing nail psoriasis in patients with psoriatic arthritis, with or without axial manifestations, irrespective of severity of nail involvement. Reduction of nail disease was also associated with response across all musculoskeletal and skin manifestations of psoriatic arthritis.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Psoriasis
/
Artritis Psoriásica
/
Enfermedades de la Uña
/
Uñas Malformadas
Tipo de estudio:
Etiology_studies
Límite:
Humans
Idioma:
En
Revista:
Br J Dermatol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Alemania